Chemical Biology Letters
Keywords: item categories
Tuberculosis (TB) has persistently posed a formidable challenge throughout human history as a contagious disease. Despite the gravity of the global TB burden, the advancement of available therapeutic treatment has been minimal over several decades. The emergence of drug-resistant M. tb has diminished the efficacy of existing treatments. Given the escalating global TB crisis, expediting the drug discovery process is paramount, demanding the development of novel drugs capable of eliminating the drug-resistant as well as latent TB infections. Furthermore, the new drugs should shorten the duration of treatment. This article summarises the current landscape of tuberculosis treatment options, shedding light on the latest efforts in the drug discovery process. This review also delves into various molecular pathways of the mycobacterium in order to ascertain unique drug targets along with their latest novel inhibitors, thus providing a comprehensive platform for the readers.
Discover more from RSYN FYI
Subscribe to get the latest posts sent to your email.